Pet/ct-guided radioactive seed therapy for cancer
Part of Cancer clinical trials.
This trial uses PET/CT scans to precisely place tiny radioactive seeds inside your tumor. The goal is to deliver the right amount of radiation directly to the cancer while sparing healthy tissue, potentially improving treatment effectiveness and reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed cancer diagnosis (solid tumor, lymphoma, or a localized leukemia lesion) that can be treated with radioactive seed implantation.
- Your tumor must be visible on a CT or PET/CT scan and in a location that allows image-guided placement of the seeds.
- Your doctor must expect you to live at least 6 more months.
- You must be able to undergo PET/CT imaging with specific tracers (like FDG or tumor-specific ones).
- You must sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines tiny radioactive seeds placed directly into tumors with an immunotherapy drug that helps the immune system fight cancer. It is for patients with advanced or returning tumors that have not responded well to other treatments, and aims to see if this combination can shrink tumors and improve outcomes.
This study tests a combination approach for people with cancer that has spread to multiple spots outside the brain. It uses a procedure that places tiny radioactive seeds directly into the tumor, along with standard systemic therapy (like chemo or immunotherapy), to see if this helps control the cancer better.
This trial tests a procedure where tiny radioactive seeds are placed into spinal tumors to relieve pain and control growth. It is for people with cancer that has spread to the bone and who are able to undergo the procedure safely.
This study is testing a treatment that implants tiny radioactive seeds (brachytherapy) directly into a few growing cancer spots, along with your regular systemic therapy, for people with lung or colorectal cancer that has spread. It aims to control those growing spots and potentially improve how long the treatment keeps working.
This trial is testing a new way to treat prostate cancer by placing a tiny radioactive seed directly into the main tumor. It's for men with early-stage, slow-growing cancer who have just one visible tumor on MRI.
This trial tests a special imaging technique that may help doctors see and stage solid tumors more precisely. It uses a targeted radioactive tracer to highlight cancer cells during PET and SPECT scans, which could help plan better treatment.
Hear when a new Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.